PubMed Health⌕ Search

Biomedical subjects

D K Hansen

Publications and source records attributed to D K Hansen.

51 records · Page 3Linked to original sources
PubMed1986

Effects of nitrous oxide on macromolecular content and DNA synthesis in rat embryos.

Exposure of pregnant rats to the anesthetic gas, nitrous oxide (N2O), has been reported to be teratogenic. This gas decreases activity of the enzyme 5-methyltetrahydrofolate homocysteine methyltransferase (methionine synthetase) and alters the level and distribution of folic acid derivatives in embryonic tissue. Because of their role in purine, thymidine and amino acid metabolism, alterations in the levels of various folate forms could affect macromolecular synthesis. The effect of N2O exposure on the number of somites, the content of DNA, RNA and protein as well as the incorporation of thymidine, deoxyuridine or serine into DNA were determined. Pregnant rats were exposed for 24 hr to 50% N2O-50% O2 beginning on day 10 of gestation. Control animals were exposed to 50% N2-50% O2. Embryos were removed and cultured for 4 hr using a rodent whole embryo culture system in medium containing radiolabeled precursors for DNA. Treatment with N2O had no effect on somite number, RNA or protein content. However, there was a significant decrease in DNA content. There was an increase in the incorporation of thymidine into DNA, but the incorporation of deoxyuridine and serine into DNA was decreased. These data demonstrate that treatment of pregnant rats with N2O results in decreased DNA synthesis and content in exposed embryos.

5-Methyltetrahydrofolate-Homocysteine S-Methyltran↗
PubMed1986

Effect of route of administration on phenytoin teratogenicity in A/J mice.

Acute administration of the anticonvulsant drug, phenytoin (PHT) has been shown to result in embryotoxicity and teratogenicity in several strains of mice. The A/J strain is reported to be most susceptible to the effects of the drug including an increased incidence of resorptions and orofacial clefts in treated animals. When administered chronically, the drug has been shown to be teratogenic in the absence of maternal toxicity and embryolethality in Swiss Webster mice [Hansen and Billings, 1985]. In this paper, we have compared the embryopathic effects of chronic and acute administrations of PHT to A/J mice. PHT was administered to pregnant females by intraperitoneal (i.p.) injection on day 10 of gestation at a dose of either 60 or 75 mg/kg body weight. Alternatively, PHT was added to ground chow and fed to animals prior to and throughout gestation; animals received a daily dose of either 60 or 75 mg/kg body weight. Pregnant animals were sacrificed on day 18 or 19 of gestation, and fetuses were examined for the presence of orofacial clefts and other anomalies. There was a significant increase in the frequency of cleft lip and palate in animals receiving the drug by i.p. administration, but there was no increase in the incidence of clefts if the drug were added to the diet. The results of this study reiterate the importance of the route of administration of a drug in determining its embryopathic effect.

Abnormalities, Drug-Induced↗
PubMed1985

Phenytoin teratogenicity and effects on embryonic and maternal folate metabolism [published errtum appears in Teratology 1986 Dec;34(3):487].

It has been postulated that the mechanism of teratogenicity of the anticonvulsant drug phenytoin (PHT), is via a deficiency of folic acid. To test this hypothesis, Swiss Webster mice were administered PHT in the diet prior to and throughout gestation. Animals received a daily dose of approximately 75 mg/kg body weight. The maternal plasma PHT levels were within the therapeutic range for this drug. This dose increased the incidence of malformations, primarily cleft palate, in the absence of embryolethality. There was a decrease in maternal plasma folate levels on day 12 of gestation but no effect on days 10 and 18. Even in the presence of a maternal folate deficiency on day 12, PHT had no effect on total embryonic folate levels on days 10, 12, and 14. Previous experiments have demonstrated that PHT decreases activity of the enzyme 5,10-methylenetetrahydrofolate reductase in the liver of nonpregnant Swiss Webster mice. Data from the current study indicate that this enzyme activity is also decreased in hepatic tissue of pregnant mice, but it is not altered in embryos on the days examined. These data show that a teratogenic dose of PHT affects maternal folate metabolism. However embryonic folate metabolism, when measured in total embryos, was not affected.

Abnormalities, Drug-Induced↗
PubMed1985

Effects of nitrous oxide on maternal and embryonic folate metabolism in rats.

Deficiency of the vitamin, folic acid, or exposure to the anesthetic gas, nitrous oxide (N2O), has been reported to be teratogenic in rats. N2O oxidizes the vitamin B12 prosthetic group of methionine synthetase. This enzyme converts the plasma folate form, 5-methyltetrahydrofolate, to tetrahydrofolate and catalyzes the methylation of homocysteine to methionine. To assess the effects of N2O on folate levels in embryos, pregnant rats were exposed to a mixture of 50% N2O:50% O2 for 4, 24 or 48 h. Animals were sacrificed on day 14 of gestation immediately following treatment. Exposure to N2O was not acutely embryotoxic. It significantly inhibited methionine synthetase activity in maternal liver as well as embryonic tissue. Exposure to N2O for 48 h led to a loss of folates from liver and embryos and marked changes in the distribution of folates within these tissues. Specifically, the levels of nonmethylated folates including tetrahydrofolate in embryonic tissue were reduced by 50%, a loss which could be very significant in regard to embryonic macromolecular synthesis.

5-Methyltetrahydrofolate-Homocysteine S-Methyltran↗
PubMed1983

Comparative teratogenicity of phenytoin among several inbred strains of mice.

Inbred strains of mice differ in their response to the embryopathic effects of phenytoin (PHT). A/J animals, the most susceptible strain, were mated to C57BL/6J mice, the most resistant strain. The susceptibility of the F1 hybrid offspring was determined by the susceptibility of the mother. B6AF1 animals were as resistant as C57BL/6J parental mice, and AB6F1 hybrids were as susceptible as A/J mice. This was especially evident when orofacial anomalies were tallied. (B6A)F2 hybrid offspring were as resistant as their C57BL/6J grandparents.

Abnormalities, Drug-Induced↗
PubMedDate not supplied

Behavioral teratology and dominant lethal evaluation of nitrous oxide exposure in rats.

Epidemiological studies have suggested that spontaneous abortion may be increased in medical personnel following the sort of chronic low-level exposure to the anesthetic gas nitrous oxide (N2O) seen in surgical or dental operatories. These results are supported by some, but not all, animal studies, and results are less well established at low exposure levels. Behavioral effects in exposed animal offspring have also been observed, but again not in all studies. To further examine this problem, we conducted the present experiments. Adult male or female rats were exposed to trace concentrations of N2O (0%, 0.1%, 0.5%, or 1.0% in air) for 6 h daily either throughout gestation (females) or for 9 weeks (males). Offspring from treated adults were subjected to an extensive behavioral test battery. There were no clear dose-response effects on any of eight behavioural tests for any offspring. Maternal and offspring weights were normal from conception through adulthood. Additionally, we studied effects of N2O on male fertility by mating treated males with untreated females and examining uterine contents. There was no evidence for a substantial decline in fertility of exposed males, although there was a small dose-related trend for resorptions to increase and live births to decrease with increasing paternal N2O exposure. There results suggest that there is little alteration in male or female fertility following chronic exposure to low levels of N2O. There are also no significant long-term behavioral alterations in offspring exposed gestationally to trace levels of N2O via dam or sire.

Animals↗
PubMedDate not supplied

Antisense modulation of 5,10-methylenetetrahydrofolate reductase expression produces neural tube defects in mouse embryos.

The role of folate metabolism in producing neural tube defects (NTDs) in humans is unknown. In the current study, antisense oligodeoxyribonucleotide technology was utilized to disrupt normal expression of the gene for 5,10-methylenetetrahydrofolate reductase (MTHFR) in organogenesis-stage mouse embryos. Two different antisense probes were microinjected into the amniotic sac of gestation day (GD) 8 mouse embryos with PBS or scrambled sense oligodeoxyribonucleotides injected into control embryos. Concentration-dependent increases in the frequencies of embryos with NTDs were observed for both antisense sequences. The level of mRNA for MTHFR was decreased in embryos treated with the higher concentration of one antisense sequence, indicating that the sequence is able to decrease gene expression. 5-methyltetrahydrofolate, the product of the MTHFR reaction, was able to decrease the incidence of antisense-induced NTDs, but co-injection with L-methionine did not. These results suggest that reduced expression of MTHFR may play a role in producing NTDs.

Animals↗
PubMedDate not supplied

Dose-response of retinoic acid induced stress protein synthesis and teratogenesis in mice.

Stress proteins are synthesized in response to a variety of stressors, including several teratogenic agents. However, their role, if any, in the teratogenic process is unknown. We have previously demonstrated that all-trans-retinoic acid administered to pregnant CD-1 mice on gestational day 11 or 13 produced limb defects and cleft palate near term in a dose-responsive manner. This chemical also induced the synthesis of several nuclear stress proteins in embryonic tissues within several hours of dosing. The stress proteins were only observed in tissues that eventually became malformed and not in tissues that appeared normal at term. In the current work, we examined the stress response in embryonic target tissues after several different doses of retinoic acid. The nuclear stress proteins were synthesized in a dose-related manner and at a lower retinoic acid dose than doses producing malformations in the corresponding tissue at birth. Each individual stress protein and the total stress protein response were highly correlated, across dose, with the respective malformations observed at term.

Abnormalities, Drug-Induced↗
PubMedDate not supplied

Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro.

Recent work from humans and chick embryos has suggested that homocysteine may play a role in producing neural tube defects (NTDs). In an effort to determine if homocysteine is able to produce NTDs in mammalian embryos, mouse embryos were explanted on GD 8 and cultured for 44 h. When either homocysteine or homocysteine thiolactone was added to the culture medium, treated embryos developed as well as controls and had closed neural tubes. Homocysteine thiolactone was also microinjected into the amniotic sac of mouse embryos. Again, development proceeded normally with no significant increase in the number of embryos with open neural tubes at the end of the culture period. HPLC analysis of embryonic thiols 24 h after microinjection revealed a significant increase in embryonic cystathionine levels. These data suggest that homocysteine does not produce NTDs in mouse embryos cultured in vitro and that early organogenesis-stage embryos are able to metabolize homocysteine.

Abnormalities, Drug-Induced↗
PubMedDate not supplied

Evaluation of the BBMEC model for screening the CNS permeability of drugs.

Combinatorial synthesis and high-throughput pharmacology screening have greatly increased compound throughput in modern drug-discovery programs. For CNS drugs, it is also important to determine permeability to the blood--brain barrier. Yet, given the increased pace of discovery, it difficult to conduct this screen in a timely fashion. In this presentation, we describe several improvements to an existing CNS permeability screen, the bovine brain microvessel endothelial cell (BBMEC) model. By implementation of these incremental process improvements, we have achieved a robust, facile screen for determination of CNS permeability of multiple compounds.

Animals↗
PubMedDate not supplied

Renal effects of fumonisin mycotoxins in animals.

Fumonisins are mycotoxins produced worldwide by Fusarium fungi, principally F. moniliforme. The fungus is present in virtually all harvested corn, but the toxins produced are variable. The toxins, especially fumonisin B1, cause mild to fatal diseases in animals, with peculiar species specificity for the dominant signs of toxicity. The mechanism of toxicity is poorly understood, but it appears to be related to interference with sphingolipid biosynthesis in multiple organs. Whereas brain, lung, and liver are well-known target organs, toxic effects on the kidney are also widespread and have only recently begun to be characterized. Increased urine volume and decreased osmolarity are early changes associated with the toxin, as are increased excretions of high- and low-molecular-weight proteins. Enzymuria in vivo, reduced ion transport in vitro, and elevation of free sphinganine in renal tissue and in urine are present. An increase in serum creatinine and blood urea nitrogen and histopathologic change in renal tubules occur later and at higher doses. The morphologic change principally affects the junction of cortex and medulla and includes prominent apoptosis of epithelial cells of proximal convoluted tubules. Nephrotoxicity has been reported in several species, and in rats and rabbits, the kidney appears to be the most sensitive target organ.

Animals↗
PubMedDate not supplied

The effect of teratogens on maternal corticosterone levels and cleft incidence in A/J mice.

It is unknown whether orofacial clefting, one consequence of teratogenic exposure, results from a direct interaction between the teratogen and the embryonic palate, or indirectly from maternal alterations caused by the teratogen. In the current study pregnant A/J mice were exposed to one of three cleft-inducing agents in order to examine the relationship between drug-induced clefting and the response of maternal plasma corticosterone to drug administration. The agents used, haloperidol (HAL), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), or phenytoin (PHT), were administered in teratogenic doses between 0800 and 0930 on gestational day 10 (GD 10). For corticosterone determinations, mice were dosed on GD 10, and blood was collected at 1, 4, 24, or 48 hr after dosing. For fetal evaluation of cleft lip and/or cleft palate, mice were dosed on GD 10 and killed on GD 18. Phenytoin was the most potent inducer of cleft lip and palate and induced a sustained elevation of plasma corticosterone in maternal animals. The other treatments, in order of decreasing potency to induce clefting and/or cause an elevation of corticosterone in plasma were 2,4,5-T > HAL > controls. Correlations between maternal corticosterone levels and clefting incidence were very high at all time points examined; total exposure (area under the curve) was also highly correlated. A linear relationship between drug-induced increases in maternal corticosterone levels and the incidence of clefting in A/J mice was evident. Based on these findings, we believe that increased maternal corticosterone levels may play a role in orofacial clefting in A/J mice.

2,4,5-Trichlorophenoxyacetic Acid↗
PubMedDate not supplied

Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.

Phenytoin (PHT) is teratogenic in A/J but not in C57BL/6J mice. Teratogenesis in F1 hybrid offspring of these two strains is dependent on the susceptibility of the maternal parent. Hepatic microsomes from untreated pregnant A/J females produced more of both the phenolic and diol metabolites than did microsomes from pregnant C57BL/6J females. This difference disappeared when the animals were pretreated with phenobarbital or phenytoin. It seems unlikely that the genetic difference in susceptibility to PHT-induced teratogenesis can be explained on the basis of maternal metabolism of the drug.

Animals↗